首页> 外文OA文献 >Structure and ligand-binding site characteristics of the human P2Y11 nucleotide receptor deduced from computational modelling and mutational analysis
【2h】

Structure and ligand-binding site characteristics of the human P2Y11 nucleotide receptor deduced from computational modelling and mutational analysis

机译:人类P2Y11核苷酸受体的结构和配体结合位点特征从计算建模和突变分析推导。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The P2Y11-R (P2Y11 receptor) is a less explored drug target. We computed an hP2Y11-R (human P2Y11) homology model with two templates, bovine-rhodopsin (2.6 Å resolution; 1 Å=0.1 nm) and a hP2Y1–ATP complex model. The hP2Y11-R model was refined using molecular dynamics calculations and validated by virtual screening methods, with an enrichment factor of 5. Furthermore, mutational analyses of Arg106, Glu186, Arg268, Arg307 and Ala313 confirmed the adequacy of our hP2Y11-R model and the computed ligand recognition mode. The E186A and R268A mutants reduced the potency of ATP by one and three orders of magnitude respectively. The R106A and R307A mutants were functionally inactive. We propose that residues Arg106, Arg268, Arg307 and Glu186 are involved in ionic interactions with the phosphate moiety of ATP. Arg307 is possibly also H-bonded to N6 of ATP via the backbone carbonyl. Activity of ATP at the F109I mutant revealed that the proposed π-stacking of Phe109 with the adenine ring is a minor interaction. The mutation A313N, which is part of a hydrophobic pocket in the vicinity of the ATP C-2 position, partially explains the high activity of 2-MeS-ATP at P2Y1-R as compared with the negligible activity at the P2Y11-R. Inactivity of ATP at the Y261A mutant implies that Tyr261 acts as a molecular switch, as in other G-protein-coupled receptors. Moreover, analysis of cAMP responses seen with the mutants showed that the efficacy of coupling of the P2Y11-R with Gs is more variable than coupling with Gq. Our model also indicates that Ser206 forms an H-bond with Pγ (the γ-phosphate of the triphosphate chain of ATP) and Met310 interacts with the adenine moiety.
机译:P2Y11-R(P2Y11受体)是一种较少探索的药物靶标。我们计算了一个带有两个模板的hP2Y11-R(人类P2Y11)同源模型,牛视紫红质(2.6Å分辨率;1Å= 0.1nm)和一个hP2Y1-ATP复合模型。 hP2Y11-R模型使用分子动力学计算进行了精炼并通过虚拟筛选方法进行了验证,富集因子为5。此外,对Arg106,Glu186,Arg268,Arg307和Ala313进行的突变分析证实了我们的hP2Y11-R模型和计算的配体识别模式。 E186A和R268A突变体分别将ATP的效力降低了一个和三个数量级。 R106A和R307A突变体是功能失活的。我们建议,残基Arg106,Arg268,Arg307和Glu186参与与ATP磷酸部分的离子相互作用。 Arg307也可能通过主链羰基H键合至ATP的N6。 ATP在F109I突变体上的活性表明,拟议的Phe109与腺嘌呤环的π堆积是次要的相互作用。突变A313N是ATP C-2位置附近疏水口袋的一部分,部分解释了2-MeS-ATP在P2Y1-R上的高活性,而在P2Y11-R上的活性可忽略不计。与其他G蛋白偶联受体一样,Y261A突变体的ATP失活意味着Tyr261充当分子开关。此外,对突变体观察到的cAMP反应的分析表明,P2Y11-R与Gs偶联的功效比与Gq偶联的变异更大。我们的模型还表明,Ser206与Pγ(ATP三磷酸链的γ-磷酸酯)形成H键,而Met310与腺嘌呤部分相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号